These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16181356)

  • 1. Carbonic anhydrase, acetazolamide and Helicobacter pylori infection.
    Buzás GM
    Helicobacter; 2005 Oct; 10(5):444. PubMed ID: 16181356
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study.
    Shahidzadeh R; Opekun A; Shiotani A; Graham DY
    Helicobacter; 2005 Apr; 10(2):136-8. PubMed ID: 15810944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis for the Inhibition of Helicobacter pylori α-Carbonic Anhydrase by Sulfonamides.
    Modak JK; Liu YC; Machuca MA; Supuran CT; Roujeinikova A
    PLoS One; 2015; 10(5):e0127149. PubMed ID: 26010545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
    Nishimori I; Vullo D; Minakuchi T; Morimoto K; Onishi S; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2182-8. PubMed ID: 16459077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I; Minakuchi T; Kohsaki T; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3585-94. PubMed ID: 17482815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori CAs inhibition.
    Bernardoni BL; La Motta C; Carradori S; D'Agostino I
    Enzymes; 2024; 55():213-241. PubMed ID: 39222992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
    Nishimori I; Minakuchi T; Morimoto K; Sano S; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2006 Mar; 49(6):2117-26. PubMed ID: 16539401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of brain carbonic anhydrase protects against 4-aminopyridine seizures.
    Mihály A; Bencsik K; Nógrádi A
    Acta Physiol Hung; 1994; 82(2):99-108. PubMed ID: 7887180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Topical carbonic anhydrase inhibitors for glaucoma].
    Geyer O; Michaeli-Cohen A
    Harefuah; 1996 May; 130(10):705-7. PubMed ID: 8794665
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel carbonic anhydrase inhibitors for the treatment of
    Supuran CT
    Expert Opin Investig Drugs; 2024 May; 33(5):523-532. PubMed ID: 38517734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets.
    Nishimori I; Onishi S; Takeuchi H; Supuran CT
    Curr Pharm Des; 2008; 14(7):622-30. PubMed ID: 18336307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification. 1999; 43 (5): 344-6.
    Chakraborty P; Villada JR; Tinu AT
    J R Coll Surg Edinb; 1999 Dec; 44(6):411-2. PubMed ID: 10612969
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting carbonic anhydrase to treat diabetic retinopathy: emerging evidences and encouraging results.
    Weiwei Z; Hu R
    Biochem Biophys Res Commun; 2009 Dec; 390(3):368-71. PubMed ID: 19833100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibition in ophthalmology: carbonic anhydrases in cornea, lens, retina and lacrimal gland.
    Wistrand PJ
    EXS; 2000; (90):413-24. PubMed ID: 11268527
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective Inhibition of
    Grande R; Carradori S; Puca V; Vitale I; Angeli A; Nocentini A; Bonardi A; Gratteri P; Lanuti P; Bologna G; Simeone P; Capasso C; De Luca V; Supuran CT
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769015
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acetazolamide--are there reasons for its revival in antiepileptic treatment?].
    Hoddevik GH
    Tidsskr Nor Laegeforen; 2000 Mar; 120(9):1042-5. PubMed ID: 10833964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The periplasmic alpha-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation.
    Marcus EA; Moshfegh AP; Sachs G; Scott DR
    J Bacteriol; 2005 Jan; 187(2):729-38. PubMed ID: 15629943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, purification and preliminary crystallographic analysis of the complex of Helicobacter pylori α-carbonic anhydrase with acetazolamide.
    Modak JK; Revitt-Mills SA; Roujeinikova A
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Nov; 69(Pt 11):1252-5. PubMed ID: 24192362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acclimatizing with acetazolamide.
    Basnyat B
    J Travel Med; 2012; 19(5):281-3. PubMed ID: 22943266
    [No Abstract]   [Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity.
    Supuran CT
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):11-5. PubMed ID: 22335448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.